PharmAust Limited logo

PharmAust Limited

ASX:PAA.AX

Overview | Financials
Company Name PharmAust Limited
Symbol PAA.AX
Currency AUD
Price 0.19
Market Cap 92,460,650
Dividend Yield 0%
52-week-range 0.068 - 0.535
Industry Biotechnology
Sector Healthcare
CEO Dr. Michael Thurn Ph.D.
Website https://www.pharmaust.com

An error occurred while fetching data.

About PharmAust Limited

PharmAust Limited develops targeted cancer therapeutics for humans and animals in Switzerland, Australia, Sweden, the United States, and internationally. The company develops drug discovery intellectual property for the treatment of various cancers, and neurological diseases. Its lead candidate is Monepantel (MPL), a small molecule drug which is in Phase II

Related Stocks

Respiri Limited logo

Respiri Limited

RSH.AX

0.042 AUD

Nova Eye Medical Limited logo

Nova Eye Medical Limited

EYE.AX

0.187 AUD

Financials

Numbers are in millions USD

Numbers are in millions USD